Loading...
Loading...
EVOK| Name | Value |
|---|---|
| Revenues | 1,562.9K |
| Cost of Revenue | 34.9K |
| Gross Profit | 1,528.0K |
| Operating Expense | 3,131.4K |
| Operating I/L | -1,603.4K |
| Other Income/Expense | -90.5K |
| Interest Income | 35.6K |
| Pretax | -1,693.9K |
| Income Tax Expense | 75.1K |
| Net Income/Loss | -1,693.9K |
Evoke Pharma, Inc. is a specialty pharmaceutical company specializing in the development and commercialization of drugs for gastroenterological disorders. Its primary focus is on the development of Gimoti, a metoclopramide nasal spray designed to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company targets gastroenterologists, internal medicine specialists, primary care physicians, and select healthcare providers as its primary customer base.
